Research company focused on developing cancer treatments with STING agonists.
3
Funding Rounds
$4.2m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Ni***** Ma*** | - | - | - |
Sy***** Ca***** |
|
- |